Josefin Snellman

1.1k total citations
29 papers, 748 citations indexed

About

Josefin Snellman is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Josefin Snellman has authored 29 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 12 papers in Cellular and Molecular Neuroscience and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Josefin Snellman's work include Migraine and Headache Studies (20 papers), Trigeminal Neuralgia and Treatments (11 papers) and Neuropeptides and Animal Physiology (6 papers). Josefin Snellman is often cited by papers focused on Migraine and Headache Studies (20 papers), Trigeminal Neuralgia and Treatments (11 papers) and Neuropeptides and Animal Physiology (6 papers). Josefin Snellman collaborates with scholars based in Switzerland, United States and Denmark. Josefin Snellman's co-authors include Scott Nawy, David Zenisek, Messoud Ashina, Mohammad Al‐Mahdi Al‐Karagholi, Bhupesh Mehta, Faisal Mohammad Amin, Cristina López López, Cristina Lopez‐Lopez, Lanfranco Pellesi and Jens Hannibal and has published in prestigious journals such as Neuron, Journal of Neuroscience and Blood.

In The Last Decade

Josefin Snellman

28 papers receiving 734 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Josefin Snellman 385 317 300 214 140 29 748
Tiziana Cesetti 460 1.2× 248 0.8× 275 0.9× 172 0.8× 128 0.9× 6 756
Annabelle R. Charbit 504 1.3× 138 0.4× 112 0.4× 234 1.1× 266 1.9× 14 797
Adisa Kuburas 560 1.5× 249 0.8× 190 0.6× 197 0.9× 209 1.5× 30 909
Boyan Todorov 156 0.4× 248 0.8× 220 0.7× 46 0.2× 39 0.3× 10 497
T. R. Tölle 121 0.3× 345 1.1× 239 0.8× 100 0.5× 252 1.8× 10 617
Sandra Roeske 131 0.3× 283 0.9× 181 0.6× 60 0.3× 101 0.7× 19 598
Roberta Anelli 52 0.1× 330 1.0× 201 0.7× 207 1.0× 93 0.7× 12 755
Annelies Van Dycke 460 1.2× 466 1.5× 131 0.4× 154 0.7× 90 0.6× 37 988
Blanca Marquez de Prado 216 0.6× 255 0.8× 93 0.3× 95 0.4× 155 1.1× 14 608
Aurélie Stil 52 0.1× 333 1.1× 210 0.7× 193 0.9× 128 0.9× 7 624

Countries citing papers authored by Josefin Snellman

Since Specialization
Citations

This map shows the geographic impact of Josefin Snellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josefin Snellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josefin Snellman more than expected).

Fields of papers citing papers by Josefin Snellman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josefin Snellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josefin Snellman. The network helps show where Josefin Snellman may publish in the future.

Co-authorship network of co-authors of Josefin Snellman

This figure shows the co-authorship network connecting the top 25 collaborators of Josefin Snellman. A scholar is included among the top collaborators of Josefin Snellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josefin Snellman. Josefin Snellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raffaelli, Bianca, et al.. (2024). Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation. Cephalalgia. 44(6). 2225304545–2225304545. 5 indexed citations
2.
Raffaelli, Bianca, Thien Phu, Basit Ali Chaudhry, et al.. (2024). Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial. Cephalalgia. 44(1). 2215267972–2215267972. 9 indexed citations
3.
Al‐Khazali, Haidar M., Håkan Ashina, Rune Häckert Christensen, et al.. (2024). Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab. Cephalalgia. 44(6). 2225303790–2225303790. 2 indexed citations
4.
5.
Pozo‐Rosich, Patricia, David Doležil, Koen Paemeleire, et al.. (2024). Early Use of Erenumab vs Nonspecific Oral Migraine Preventives. JAMA Neurology. 81(5). 461–461. 16 indexed citations
6.
Vries, Tessa de, Eloísa Rubio‐Beltrán, Antoon van den Bogaerdt, et al.. (2024). Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab. British Journal of Pharmacology. 181(12). 1720–1733. 7 indexed citations
7.
Agosti, R., Oliver Findling, Peter L. Myers, et al.. (2023). Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study. Pain and Therapy. 12(2). 575–591. 2 indexed citations
8.
9.
Phu, Thien, Christina Deligianni, Josefin Snellman, et al.. (2023). Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans. Brain. 146(12). 5224–5234. 18 indexed citations
10.
Pellesi, Lanfranco, Mohammad Al‐Mahdi Al‐Karagholi, Roberto De Icco, et al.. (2022). Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study. Frontiers in Neurology. 13. 871176–871176. 11 indexed citations
11.
Lampl, Christian, et al.. (2022). Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials. The Journal of Headache and Pain. 23(1). 104–104. 14 indexed citations
12.
Phu, Thien, Messoud Ashina, Lars Bendtsen, et al.. (2022). Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study. The Journal of Headache and Pain. 23(1). 61–61. 43 indexed citations
13.
Pozo‐Rosich, Patricia, Christian Lucas, Charly Gaul, et al.. (2021). Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study. Pain and Therapy. 10(2). 1691–1708. 26 indexed citations
14.
Ohlsson, Lena, Erik Kronvall, Cen Xu, Josefin Snellman, & Lars Edvinsson. (2019). Erenumab (AMG334) An Antagonist to Canonical CGRP-Receptor Does Not Impair Vasodilatory or Contractile Responses to Other Agents In Human Isolated Cerebral Arteries (S17.002). Neurology. 92(15_supplement). 2 indexed citations
15.
Mehta, Bhupesh, Josefin Snellman, Shan Chen, Wei Li, & David Zenisek. (2013). Synaptic Ribbons Influence the Size and Frequency of Miniature-like Evoked Postsynaptic Currents. Neuron. 77(3). 516–527. 51 indexed citations
16.
Snellman, Josefin, Bhupesh Mehta, Norbert Babai, et al.. (2011). Acute destruction of the synaptic ribbon reveals a role for the ribbon in vesicle priming. Nature Neuroscience. 14(9). 1135–1141. 102 indexed citations
17.
Snellman, Josefin, David Zenisek, & Scott Nawy. (2009). Switching between transient and sustained signalling at the rod bipolar‐AII amacrine cell synapse of the mouse retina. The Journal of Physiology. 587(11). 2443–2455. 32 indexed citations
18.
Snellman, Josefin, Tejinder Kaur, Yin Shen, & Scott Nawy. (2008). Regulation of ON bipolar cell activity. Progress in Retinal and Eye Research. 27(4). 450–463. 52 indexed citations
19.
Snellman, Josefin & Scott Nawy. (2004). cGMP-Dependent Kinase Regulates Response Sensitivity of the Mouse On Bipolar Cell. Journal of Neuroscience. 24(29). 6621–6628. 54 indexed citations
20.
Snellman, Josefin & Scott Nawy. (2002). Regulation of the Retinal Bipolar Cell mGluR6 Pathway by Calcineurin. Journal of Neurophysiology. 88(3). 1088–1096. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiziana Cesetti Breakdown of academic impact, for papers by Annabelle R. Charbit Breakdown of academic impact, for papers by Adisa Kuburas Breakdown of academic impact, for papers by Boyan Todorov Breakdown of academic impact, for papers by T. R. Tölle Breakdown of academic impact, for papers by Sandra Roeske Breakdown of academic impact, for papers by Roberta Anelli Breakdown of academic impact, for papers by Annelies Van Dycke Breakdown of academic impact, for papers by Blanca Marquez de Prado Breakdown of academic impact, for papers by Aurélie Stil
Rankless by CCL
2026